Andrew John Hugh MacIntyre Sims insider trades
Open-market stock purchases and sales by Andrew John Hugh MacIntyre Sims, Chief Financial Officer at Plus Therapeutics, Inc, from SEC Form 4 filings since Feb 6, 2020.
Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +192%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 14, 2026 | PSTV Plus Therapeutics, Inc | Bought (not open market) | — |
| Apr 1, 2026 | PSTV Plus Therapeutics, Inc | Bought (not open market) | — |
| Apr 1, 2026 | PSTV Plus Therapeutics, Inc | Bought (not open market) | — |
| Feb 25, 2026 | PSTV Plus Therapeutics, Inc | Bought (not open market) | — |
| Feb 25, 2026 | PSTV Plus Therapeutics, Inc | Bought (not open market) | — |
| Jan 1, 2026 | PSTV Plus Therapeutics, Inc | Bought (not open market) | — |
| Nov 4, 2025 | PSTV Plus Therapeutics, Inc | Bought | $10.2K |
Companies traded
- PSTV Plus Therapeutics, Inc: 9 buys, last May 14, 2026
Get free alerts when Andrew John Hugh MacIntyre Sims files a new trade →